The story we will be hearing a great deal of in the coming days and weeks:
Now that a jury in San Francisco has decided that exposure to Monsanto’s herbicide Roundup (glyphosate) was responsible for California groundskeeper Dewayne Johnson’s cancer, the movement to restrict the herbicide has been re-energized.
Carey Gillam, director of research at the anti-GMO group U.S. Right to Know, who worked closely with the lawyers suing Monsanto, said following the verdict that “It is time for public officials across the globe to act to protect public health and not corporate profits.” French President Emmanuel Macron is on record trying to ban it and activists organizations in numerous countries are already attempting to leverage the jury’s verdict.
A judge in Brazil recently suspended the use of the herbicide, pending a review by the nation’s agriculture ministry, and Europe may reassess the costs and benefits of a ban over the next five years. The UK retailer Homebase is reviewing its sale of the weed killer following the verdict. And depending upon how Bayer’s announced appeal plays out (Bayer recently acquired Monsanto) and the fate of numerous glyphosate cancer suits to come, it’s not out of the question that manufacturers of generic glyphosate will begin reassessing their potential liability in keeping the herbicide on the market.
The ruling comes despite hundreds of studies that have found that popular weedkiller to be safe as used. Read more